B-ALL
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
B-ALL
May 29, 2024, 15:16 |
Blog
Chen Lin: Updated results from FELIX for obecabtagene autoleucel in B-ALL by Elias Jabbour et al
Chen Lin, Assistant Professor at Duke Cancer Institute, shared on X/Twitter: "Updated results from FELIX for…
May 21, 2024, 07:10 |
Blog
Nitin Jain: Brief summary slide with some general concepts about assay depth
Nitin Jain, Professor of Medicine in the Department of Leukemia at The University of Texas MD…
May 15, 2024, 14:47 |
Drugs
Hagop Kantarjian: New research is expanding inotuzumab use into frontline, for MRD+, and in combination with blinatumomab
Nicholas Short, Associate Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
May 14, 2024, 10:12 |
Blog
Aaron Goodman: CD markers simplified!
Quoting Aaron Goodman on X: “CD markers simplified! CD34+ = Blast CD3+ = T-cell CD19+ = B-cell…
Jan 16, 2024, 11:37 |
Insight
Jayastu Senapati: Check out our SOHO State of the Art Review on Acute Lymphoblastic Leukemia
Jayastu Senapati, Assistant Professor at the Department of Leukemia at MD Anderson Cancer Center, shared…
Aug 31, 2023, 18:52 |
Insight
Nitin Jain: Excited to share preclinical data with CRLF2 bispecific antibody for CRLF2-rearranged B-ALL.
Quoting Nitin Jain, the Director of Leukemia CAR-T Program at the MD Anderson Cancer Center:…
All:
6
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube